prescription has been demonstrated to free up pharmacists to spend more time on providing patient-centred clinical services (NHS Pharmacy Education and Development Committee 2013). Evaluation of a New Zealand pilot indicates similar benefits might be expected in this country. Alignment with the New Zealand Health Strategy This focus area aligns with the following New Zealand Health Strategy key themes: value and high performance smart systems. Alignment with Implementing Medicines New Zealand This focus area contributes to the following IMNZ impact area: making the most of every point of care. Actions Lead accountability Priority Ministry of Health Review the pharmacy audit process to ensure it complies with the Ministry of Health In progress Community Pharmacy Services Agreement Audit Strategy 2015–2025. Review the Health and Disability Services Standards Pharmacy Ministry of Health 2016–17 – Services Standard 2010 to enable pharmacies to use PACTs. Investigate options to drive efficiencies in the medicines supply chain Ministry of Health 2016–2019 through the broader use of technology, eg, robotic dispensing. DHBs Review district need and develop and implement plans to deliver an DHBs 2016–19 accessible, sustainable and efficient medicines supply chain, and commission services to meet identified demand. Support systems to reduce prescribing and prescription errors and DHBs 2016–19 minimise pharmaceutical waste in aged care and other residential facilities. Sector Develop best-practice guidelines for dispensing. For example, ensure Pharmaceutical Society of 2016–18 that a pharmacist clinically screens every prescription before it is New Zealand (PSNZ) and dispensed. Pharmacy Council of New Zealand (PCNZ) jointly Promote a culture of open disclosure to support continuous PCNZ 2016–18 improvement and decrease the incidence of dispensing errors. Consider all relevant supply chain factors (eg, pack size, wastage, PHARMAC 2016–18 appropriate distribution for high-cost medicines) in making decisions about funded medicines (and how such medicines are prescribed, distributed and dispensed). Engage in high-quality communication about the implications of PHARMAC 2016–18 decisions for the supply chain, including factors considered. All actions in this Plan may change with any future changes in priorities, costing and funding over the five-year period it covers.
prescription has been demonstrated to free up pharmacists to spend more time on providing patient-centred clinical services (NHS Pharmacy Education and Development Committee 2013). Evaluation of a New Zealand pilot indicates similar benefits might be expected in this country. Alignment with the New Zealand Health Strategy This focus area aligns with the following New Zealand Health Strategy key themes: value and high performance smart systems. Alignment with Implementing Medicines New Zealand This focus area contributes to the following IMNZ impact area: making the most of every point of care. Actions Lead accountability Priority Ministry of Health Review the pharmacy audit process to ensure it complies with the Community Pharmacy Services Agreement Audit Strategy 2015–2025. Ministry of Health In progress Review the Health and Disability Services Standards – Pharmacy Services Standard 2010 to enable pharmacies to use PACTs. Ministry of Health 2016–17 Investigate options to drive efficiencies in the medicines supply chain through the broader use of technology, eg, robotic dispensing. Ministry of Health 2016–2019 DHBs Review district need and develop and implement plans to deliver an accessible, sustainable and efficient medicines supply chain, and commission services to meet identified demand. DHBs 2016–19 Support systems to reduce prescribing and prescription errors and minimise pharmaceutical waste in aged care and other residential facilities. DHBs 2016–19 Sector Develop best-practice guidelines for dispensing. For example, ensure that a pharmacist clinically screens every prescription before it is dispensed. Pharmaceutical Society of New Zealand (PSNZ) and Pharmacy Council of New Zealand (PCNZ) jointly 2016–18 Promote a culture of open disclosure to support continuous improvement and decrease the incidence of dispensing errors. PCNZ 2016–18 Consider all relevant supply chain factors (eg, pack size, wastage, appropriate distribution for high-cost medicines) in making decisions about funded medicines (and how such medicines are prescribed, distributed and dispensed). PHARMAC 2016–18 Engage in high-quality communication about the implications of decisions for the supply chain, including factors considered. PHARMAC 2016–18 All actions in this Plan may change with any future changes in priorities, costing and funding over the five-year period it covers.
pharmacy-action-plan-2016-2020-jun16.docx